A WT1-positive pleural neoplasm. Is it always a mesothelioma? Diagnostic pitfall of WT1 immunohistochemistry in pleural neoplasm
Article Sidebar
Main Article Content
Abstract
-
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The AJTCCM is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
How to Cite
References
Husain AN, Colby TV, Ordóñez NG, et al. Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017: Update of the Consensus Statement From the International Mesothelioma Interest Group. Arch Pathol Lab Med 2018;142(1):89- 108. https://doi.org/10.5858/arpa.2017-0124-RA.
Anwar A, Kasi A. Peritoneal Cancer. 2022 Feb 24. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022 Jan.
Laury AR, Hornick JL, Perets R, et al. PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma. Am J Surg Pathol 2010;34(5):627-35. https:// doi.org/10.1097/PAS.0b013e3181da7687.
Attanoos RL, Webb R, Dojcinov SD, Gibbs AR. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum. Histopathology 2002;40(3):237- 244. https://doi.org/10.1046/j.1365-2559.2002.01352.x.